Prospective Series of Transarterial Chemoembolization of Metastatic Colorectal Cancer to the Liver with 30–60 μm Microspheres Loaded with Irinotecan

被引：0
作者：
K. Malagari
Th Kiakidis
H. Moschouris
A. Charokopakis
C. Vergadis
N. Alevisopoulos
V. Kartsouni
Ir Panagiotou
O. Pellerin
G. Glantzounis
D. K. Filippiadis
E. Emmanouil
N. Tsavaris
G. Psarros
E. Delicha
N. Kelekis
机构：
[1] National and Kapodistrian University of Athens,Department of Radiology, Medical School
[2] Evgenidion and Attikon University Hospitals,Interventional Radiology Department
[3] Tzanion General Hospital,Department of Interventional Radiology
[4] Laikon General Hospital,Interventional Radiology
[5] Evangelismos Hospital,Department of Radiology
[6] Agios Savvas Anticancer Hospital,undefined
[7] Department of Internal Medicine,undefined
[8] Agios Savvas Anticancer Hospital,undefined
[9] Université de Paris-Citè,undefined
[10] PARCC,undefined
[11] INSERM,undefined
[12] 75006,undefined
[13] Service de Radiologie Interventionnelle Assistance Publique - Hôpitaux de Paris Hôpital Européen Georges Pompidou,undefined
[14] Ioannina University Hospital,undefined
[15] Amalia Fleming Hospital,undefined
[16] Laikon Hospital,undefined
[17] ASTAT-Statistics in Clinical Research,undefined
来源：
CardioVascular and Interventional Radiology | 2023年 / 46卷
关键词：
Drug-eluting microspheres; Liver metastatic colorectal cancer (mCRC); Irinotecan; HepaSphere™ microspheres 30–60 μm;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：880 / 890
页数：10
相关论文
共 209 条
[1]  
Lewis AL(2019)Toward a better understanding of the mechanism of action for intra-arterial delivery of irinotecan from DC Bead((TM)) (DEBIRI) Future Oncol 15 2053-2068
[2]  
Hall B(2016)Early Experience with 70–150 μm irinotecan drug-eluting beads (M1-DEBIRI) for the treatment of unresectable hepatic colorectal metastases Anticancer Res 36 3413-3418
[3]  
Akinwande O(2015)A review of conventional and drug-eluting chemoembolization in the treatment of colorectal liver metastases: principles and proof Future Oncol 11 1421-1428
[4]  
Scoggins C(2017)Review of the clinical evidence for the use of DEBIRI in the treatment of colorectal metastatic disease Cardiovasc Intervent Radiol 40 496-501
[5]  
Martin RC(2014)Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population Cardiovasc Intervent Radiol 37 154-164
[6]  
Liu DM(2017)Chemoembolization of liver cancer with drug-loading microsphere 50–100μm Oncotarget 8 5392-5399
[7]  
Thakor AS(2014)Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads: technical recommendations J Vasc Interv Radiol 25 365-369
[8]  
Baerlocher M(2020)Does bead size affect patient outcome in irinotecan-loaded beads chemoembolization plus systemic chemotherapy regimens for liver-dominant colorectal cancer? Results of an observational study Cardiovasc Intervent Radiol 43 866-874
[9]  
Alshammari MT(2020)Stressing the need for prolonged immediate surveillance after chemoembolization for liver metastases using drug-eluted beads with irinotecan Diagn Interv Imaging 101 759-760
[10]  
Lim H(2010)Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis 30 52-60
12345678910